摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-chloro-2,2,3,3-tetramethylbutane | 116496-44-7

中文名称
——
中文别名
——
英文名称
1-chloro-2,2,3,3-tetramethylbutane
英文别名
Chlorhexamethylaethan;1-Chlor-2,2,3,3-tetramethyl-butan
1-chloro-2,2,3,3-tetramethylbutane化学式
CAS
116496-44-7
化学式
C8H17Cl
mdl
MFCD19233271
分子量
148.676
InChiKey
HJPKTCDUDRYVMU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    148.5±8.0 °C(Predicted)
  • 密度:
    0.864±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Whitmore; Marker; Plambeck, Journal of the American Chemical Society, 1941, vol. 63, p. 1628
    摘要:
    DOI:
  • 作为产物:
    描述:
    六甲基乙烷吡啶氯化亚砜双氧水溶剂黄146 、 C46H40F18MnN6O6S2 作用下, 反应 25.0h, 生成 1-chloro-2,2,3,3-tetramethylbutane
    参考文献:
    名称:
    10.1002/anie.202402858
    摘要:
    AbstractThe tert‐butyl group is a common aliphatic motif extensively employed to implement steric congestion and conformational rigidity in organic and organometallic molecules. Because of the combination of a high bond dissociation energy (~100 kcal mol−1) and limited accessibility, in the absence of directing groups, neither radical nor organometallic approaches are effective for the chemical modification of tert‐butyl C−H bonds. Herein we overcome these limits by employing a highly electrophilic manganese catalyst, [Mn(CF3bpeb)(OTf)2], that operates in the strong hydrogen bond donor solvent nonafluoro‐tert‐butyl alcohol (NFTBA) and catalytically activates hydrogen peroxide to generate a powerful manganese‐oxo species that effectively oxidizes tert‐butyl C−H bonds. Leveraging on the interplay of steric, electronic, medium and torsional effects, site‐selective and product chemoselective hydroxylation of the tert‐butyl group is accomplished with broad reaction scope, delivering primary alcohols as largely dominant products in preparative yields. Late‐stage hydroxylation at tert‐butyl sites is demonstrated on 6 densely functionalized molecules of pharmaceutical interest. This work uncovers a novel disconnection approach, harnessing tert‐butyl as a potential functional group in strategic synthetic planning for complex molecular architectures.
    DOI:
    10.1002/anie.202402858
点击查看最新优质反应信息

文献信息

  • Chlorination of aliphatic hydrocarbons, aromatic compounds, and olefins in subcritical carbon tetrachloride
    作者:Kiyoshi Tanemura、Tsuneo Suzuki、Yoko Nishida、Takaaki Horaguchi
    DOI:10.1016/j.tetlet.2008.08.082
    日期:2008.11
    The reactions of various substrates including aliphatic hydrocarbons, aromatic compounds, and olefins were investigated in subcritical carbon tetrachloride. Ketones and sulfones were stable under the employed conditions. The coupling adducts between olefins and carbon tetrachloride were obtained from the reactions of olefins.
    在亚临界四氯化碳中研究了包括脂肪烃,芳族化合物和烯烃在内的各种底物的反应。酮和砜在使用条件下是稳定的。烯烃与四氯化碳之间的偶联加合物由烯烃的反应获得。
  • CHEMICAL COMPOUNDS
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:US20160159819A1
    公开(公告)日:2016-06-09
    The invention relates to pyrrolone compounds of the formula (I), wherein X, R a , R b , R c , R 1 , R 2 and R 3 are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds to control plant growth.
    本发明涉及式(I)的吡咯烷化合物,其中X,Ra,Rb,Rc,R1,R2和R3如规范中所定义。此外,本发明还涉及制备式(I)化合物的方法和中间体,包括这些化合物的除草剂组合物以及使用这些化合物控制植物生长的方法。
  • DEUTERIUM-MODIFIED CFTR MODULATORS
    申请人:VERTEX PHARMACEUTICALS (EUROPE) LIMITED
    公开号:US20190048020A1
    公开(公告)日:2019-02-14
    This invention relates to novel 4,4,5,5,7,7-hexamethyl-5,7-dihydro-4H-thieno[2,3-c]pyranyl compounds, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
  • US9605004B2
    申请人:——
    公开号:US9605004B2
    公开(公告)日:2017-03-28
  • Whitmore; Marker; Plambeck, Journal of the American Chemical Society, 1941, vol. 63, p. 1628
    作者:Whitmore、Marker、Plambeck
    DOI:——
    日期:——
查看更多